
The White House has withdrawn Dr. Heidi Overton’s nomination for FDA commissioner just a day before a Senate committee vote.
Click the title above for a link to open the Pharmaceutical Executive June 2024 issue in an interactive PDF format.
over 2 years ago
Beyond the Numbers: Extrapolating Today’s Trends Forwardover 2 years ago
Opposite Spectrumsover 2 years ago
2024 Pharm Exec Top 50 Companiesover 2 years ago
Craig Tooman: Silencing the Distractionsover 2 years ago
Regaining Trust in the Pharma Industryover 2 years ago
Succession Attack Plan: Get Strategic with Your Critical Rolesover 2 years ago
The Healthcare System is Changing—So How Should We Respond?over 2 years ago
Biotech Performance Remains Tethered to Rate Expectationsover 2 years ago
Pharm Exec Exclusive: Mark Cuban Talks Drug Pricing




